The following is a news commentary. I was a reporter at CBS News 20+ year ago when I was assigned my first stories on medical safety issues and government-pharmaceutical industry corruption for the CBS Evening News and I met Dr. […]
News reports indicate that Dan Ziegler, a Washington lobbyist counting among his clients PhRMA, Pfizer, Merck, Sanofi, Eli Lilly and Amgen, will join House Speaker Mike Johnson’s office as policy director. Public Citizen, a nonprofit consumer advocacy organization that works
(READ) New House Speaker Mike Johnson hires Pharma lobbyist to join his staff Read More »
Public Citizen’s Health Research Group wants the FDA to deny speeded up approval of a new gene therapy treatment. The advocacy group states that the treatment, SRP-9001 (Sarepta Therapeutics) for ambulatory Duchenne muscular dystrophy (DMD), intended for children aged four
(READ) Watchdogs want FDA to reject fast-tracking of new gene therapy treatment Read More »
Gabapentin has quietly become one of the most widely-prescribed drugs in America, and some say that could spell big trouble. Michael Abrams of Public Citizen explains why, as neurologist Dr. Brian Callaghan offers a counterpoint.
The following is an excerpt from the DisInformation Chronicle written by Paul D. Thacker. New documents further detail the hundreds of thousands of dollars in federal funds diverted to set up the Global Virome Project, an organization now headed by Dennis
It’s estimated that about six million people in the U.S. have the dreaded form of dementia known as Alzheimer’s disease. The search for a cure has fallen frustratingly short. Now, one pharmaceutical company says a cure, at least for early
(WATCH) Is new Alzheimer’s drug effective or “futile”? Read More »
Is the first true cure for early Alzheimer’s disease on the horizon? The makers of still unapproved drug aducanumab say — maybe. But there’s a lot of controversy surrounding the promise. Watchdogs say there’s little to no evidence the drug
Alzheimer’s Cure & Controversy; Summer Travel; Tomb of the Unknowns Read More »
The following is the May 10, 2020 cover story from Full Measure with Sharyl Attkisson. Watch the video report by clicking the link at the end of the story. We begin with questions about ethics concerning medical research on humans.
